NCT00447629View on ClinicalTrials.gov

Study Evaluating Single Doses of PPM-204 on the Electrical Pathways of the Heart

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

January 31, 2007

Study Completion Date

March 31, 2007

Conditions

Diabetes Mellitus

Interventions

DRUG

PPM-204

Trial Locations (1)

85044

Phoenix

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00447629 - Study Evaluating Single Doses of PPM-204 on the Electrical Pathways of the Heart | Biotech Hunter | Biotech Hunter